Quest Diagnostics Inc vs Atlassian Corporation PLC — how do they compare? Quest Diagnostics Inc trades at $237.5 (market cap $26.21B), while Atlassian Corporation PLC trades at $152.51 (market cap $39.10B). The key difference: Atlassian Corporation PLC is the larger of the two by market cap, and Quest Diagnostics Inc pays a 1.45% dividend while Atlassian Corporation PLC pays none. Which is the better fit depends on your goals.
| DGX | TEAM | |
|---|---|---|
Market Cap | $26.21B | $39.10B |
Sector | Health | Technology |
52-Week High | $238.50 | $182.36 |
52-Week Low | $173.49 | $57.15 |
Enterprise Value | $31.97B | $39.09B |
Dividend Yield | 1.45% | — |
Trailing returns across standard periods
Latest headlines on both assets
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →Atlassian produces software that helps teams work together more efficiently and effectively. The company provides project planning and management software, collaboration tools, and IT help desk solutions. The company operates in four segments: subscriptions (term licenses and cloud agreements), maintenance (annual maintenance contracts that provide support and periodic updates and are generally attached to perpetual license sales), perpetual license (upfront sale for indefinite usage of the software), and other (training, strategic consulting, and revenue from the Atlassian Marketplace app store). Atlassian was founded in 2002 and is headquartered in Sydney.
Read more on TEAM →